Crossmark

Current advances in immunotherapy for KRAS-Mutant pancreatic cancer

Crossref DOI link: https://doi.org/10.1007/s10238-026-02201-8

Published Online: 2026-05-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Man https://orcid.org/0009-0009-5318-8792
Wang, Xiao https://orcid.org/0009-0002-8167-2054
Li, Pengen https://orcid.org/0009-0008-2400-3296
Gong, Hongjie https://orcid.org/0009-0008-6822-9238
Wu, Jianbing https://orcid.org/0000-0002-4576-7286
Mao, Ye https://orcid.org/0009-0002-2621-0156
License Information

Text and Data Mining valid from 2026-05-31

Accepted Manuscript valid from 2026-05-31
More Information

Article History

Received: 13 February 2026

Accepted: 15 May 2026

First Online: 31 May 2026

Declarations

:

: The authors declare no competing interests.